M&A Deal Summary

Ampersand Capital Partners Acquires StageBio

On March 11, 2018, growth capital firm Ampersand Capital Partners acquired life science company StageBio

Acquisition Highlights
  • This is Ampersand Capital Partners’ 17th transaction in the Life Science sector.
  • This is Ampersand Capital Partners’ 43rd transaction in the United States.
  • This is Ampersand Capital Partners’ 1st transaction in Virginia.

M&A Deal Summary
Date 2018-03-11
Target StageBio
Sector Life Science
Buyer(s) Ampersand Capital Partners
Deal Type Buyout (LBO, MBO, MBI)

Target

StageBio

Mt Jackson, Virginia, United States
StageBio is a provider of GLP-compliant research and preclinical histology, pathology and specimen archiving services for the biopharmaceutical, medical device and contract research industries. StageBio is based in Mt Jackson, Virginia.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Ampersand Capital Partners

Wellesley, Massachusetts, United States

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 1988
PE ASSETS 2.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.

DEAL STATS #
Overall 43 of 82
Sector (Life Science) 17 of 42
Type (Buyout (LBO, MBO, MBI)) 17 of 23
State (Virginia) 1 of 1
Country (United States) 43 of 67
Year (2018) 2 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-02-08 Corpus Medical

Campbell, California, United States

Corpus Medical, Inc. is a provider of high-quality consulting and manufacturing services for the development and commercialization of innovative intervention medical devices. Corpus Medical specializes in catheter technologies, assembly of fully packaged devices and medical implants. Corpus Medical was founded in 2009 and is based in Campbell, California.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-03-20 Nexcelom Bioscience

Lawrence, Massachusetts, United States

Nexcelom Bioscience is a designer, manufacturer, and marketer of innovative Cellometer and Celigo image cytometry products designed for cell analysis in life science and biomedical research. Nexcelom Bioscience was founded in 2003 and is based in Lawrence, Massachusetts.

Buy -
Mergr

Product

Company

Legal